Asset
Coramitug
Prothena Corporation plc Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03336580 | phase1 | terminated | 2018-04-05 | 2020-07-23 | Prothena Biosciences Limited | A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis |
FDA applications (0)
This company has no applications containing this asset.